Advisor Resource Council Oncolytics Biotech Inc Transaction History

Advisor Resource Council

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$1.22 - $2.09 $122,000 - $209,000	100,000 New	100,000 $135,000
Q2 2022 Jul 27, 2022	BUY	$0.85 - $1.59 $85,000 - $159,000	100,000 New	100,000 $101,000
Q1 2022 Apr 20, 2022	SELL	$1.31 - $2.02 $131,000 - $202,000	-100,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.39 - $2.3 $139,000 - $229,999	100,000 New	100,000 $139,000
Q3 2021 Nov 16, 2021	SELL	$1.93 - $2.77 $194,930 - $279,770	-101,000 Closed	0 $0
Q2 2021 Aug 19, 2021	BUY	$2.6 - $4.64 $261,872 - $467,340	100,720 Added 35971.43%	101,000 $280,000
Q2 2021 Aug 13, 2021	BUY	$2.6 - $4.64 $728 - $1,299	280 New	280 $0

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

Stay updated on Advisor Resource Council with notifications on news.